Questions
Tournaments
Services
News
Questions
Tournaments
Questions
Questions
More
Log in
Sign Up
Log in
Sign Up
1
23
forecasters
4
1 comment
23 forecasters
Health & Pandemics
Will bimagrumab be approved for the treatment of obesity by the FDA or EMA by 2029?
Follow
share
embed
26.2%
chance
Timeline
Histogram
1d
1w
2m
all
Comments (1)
Timeline
Key Factors (0)
Question Info
Similar Questions
No key factors yet
Add some that might influence this forecast.
0 comments
29 forecasters
Semaglutide/Cagrilintide Approval by 2027
53%
chance
1 comment
53 forecasters
Oral Semaglutide Approval by 2027
83%
chance
5 comments
49 forecasters
GLP-1-based drug approval by 2029
80%
chance
4 comments
15 forecasters
Date Weight Loss Drug >25% Body Weight
Current estimate
21 Apr 2028
5 comments
63 forecasters
Semaglutide Approval Withdrawal by 2027
0.5%
chance
2 comments
8 forecasters
Will the FDA reclassify retatrutide as a biologic by 2029?
34.5%
chance
15 comments
52 forecasters
American Obesity Percentage in 2032
Current estimate
39.4%
36 comments
157 forecasters
FDA Approval for Senolytic Therapy by 2030
33%
chance